Global Market for Intravenous Immunoglobulin (IVIG )is expected to Exceed US$11.6 Billion by 2021

16 Apr
2015

6585 Views

Allied market research has recently published a report titled “Global Intravenous Immunoglobulin Market (By Application, Types and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 – 2021”. As per the report, intravenous immunoglobulin (IVIG) market is forecast to grow at 6.8% CAGR and expected to grow to $11.6 Billion by the end of 2021.

IVIG is a sterile solution of concentrated antibodies extracted from large sample of healthy donors which is injected in the bodies of patients via veins in order to treat disorders of the immune system or to boost immune system of serious illness

The demand for IVIG has been rising owing to the higher usage in ensuring primary immunodeficiency in patients and its applications to treat newer immuno-deficiency indications. The aforementioned factors would provide a fillip to the IVIG market. The concept of hyper-immune globulin is also evolving and would boost the efficiency of IVIG treatments by offering immunity to patients against different infections.

The exorbitant cost of the IVIG treatment act as a restraining factor in the growth of the IVIG market and patients are looking for cost-effective treatment such as corticosteroids to boost immunity. Also high risks of side-effects of IVIG treatment such as headache, nausea, dizziness, migraine, vomiting, fast heart rate, itching and high blood pressure associated with IVIG treatment act as a limiting factor in the growth of the IVIG market. The aforementioned side effect can be overcome by doctors intimating the patients in advance what complications to expect during and after IVIG dosage administration. Further, improved production process and the techniques of purification along with the improved plasma yield of the healthy donors would help to reduce the cost of IVIG therapy.

North America occupies the major share of the IVIG market in terms of revenue generated followed by Asia-Pacific region. There are large number of patients with immunodeficiency disease & neurological disorders in the Asia Pacific region who are adopting the IVIG therapy that would provide necessary growth momentum of the IVIG market.

Akhilesh Prabhugaonkar

Author's Bio- Akhilesh Prabhugaonkar holds a bachelor’s degree in Electronics Engineering from the reputed Vishwakarma Institute of Technology. He has a special interest in the fields of forensics, world history, international relations and foreign policy, sports, agriculture, astronomy, security, and oceanography. An ardent bibliophile and melophile, Akhilesh loves to write on topics of his interest and various other societal issues. This love for writing made him enter the professional world of content writing and pursue his career in this direction.

Developments in Biomarkers Market Answer Diagnosis Concerns

mHealth Apps Find Increased Consumer Acceptance in Global Markets

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

Avenue is an innovative subscription-based online report database.
Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
Request customizations, suggest new reports, and avail analyst support as per your requirements.
Get an access to the library of reports at any time from any device and anywhere.